Russia is on a war footing and pumping out weapons, and its struggles in Ukraine don't mean it won't look elsewhere, experts ...
Lanadelumab reduced median HAE attack rates by 98.8%. Over 70% of patients increased their dosing interval. The mean time to a dosing interval increase was 8.2 months. Perspective from Douglas H.